Dr. Mags Portman, HIV Prevention Pioneer, Dies from Mesothelioma at 44

Dr. Mags Portman, a British trailblazer in the fight to prevent and control HIV, died Wednesday after a two-year battle with mesothelioma. She was 44. Portman was lauded for triggering a significant reduction in HIV diagnoses throughout the United Kingdom by her work as a researcher, clinician and outspoken advocate. She earned international acclaim for her work as an HIV consultant at London’s Mortimer Market Centre, a progressive sexual health clinic that made pre-exposure prophylaxis (PrEP) a reality in the U.K. Portman played a key role in the 2014 study at The Royal London Hospital that proved the efficacy of the drug Truvada, which became part of PrEP and the fight against HIV in England. She was a leader in educating activists and caregivers about the lifesaving potential of PrEP. When the National Health Service delayed its approval of Truvada, Portman worked tirelessly in connecting patients and doctors to online resources and provide access to generic and affordable forms of the medication. “We’re heartbroken at the loss of Dr. Mags Portman, who was a hero and an inspiration to the HIV/AIDS advocacy community,” wrote the Elton John AIDS Foundation on the charity’s Twitter account. “Her legacy — proving the efficacy of PrEP and making it so much more accessible internationally — continues in the lives she helped save.” Mesothelioma UK, a national charity group, shared their condolences on Twitter. Mesothelioma ...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news

Related Links:

Publication date: 15 February 2021Source: Journal of Hazardous Materials, Volume 404, Part BAuthor(s): Yanhua Liu, Yang Li, Shanshan Dong, Lu Han, Ruixin Guo, Yourong Fu, Shenghu Zhang, Jianqiu Chen
Source: Journal of Hazardous Materials - Category: Environmental Health Source Type: research
Authors: Musio F Abstract INTRODUCTION: Anemia has and will continue to be a central theme in medicine particularly as clinicians are treating a burgeoning population of complex multi-organ system processes. As a result of multiple randomized controlled trials (RCTs), meta-analyses, and societal recommendations overly restrictive paradigms and under-administration of erythropoiesis stimulating agents (ESAs) have likely been followed by clinicians among all specialties. AREAS COVERED: A review of anemia in the context of chronic kidney disease, hematologic malignancies and cancer is presented with focus on the e...
Source: Expert Review of Hematology - Category: Hematology Tags: Expert Rev Hematol Source Type: research
Publication date: January 2021Source: Urology Case Reports, Volume 34Author(s): Nina Al-Saadi, Safa Al-Musawi, Yousuf Khan, Daben Dawam
Source: Urology Case Reports - Category: Urology & Nephrology Source Type: research
Publication date: Available online 10 October 2020Source: European Journal of Surgical OncologyAuthor(s): Tetsutaro Miyoshi, Satoshi Yamaguchi, Hiroshi Fujimoto, Shigeru Yoshioka, Masayuki Shiobara, Kazuo Wakatsuki, Kosuke Suda, Kotaro Miyazawa, Toshiaki Aida, Yoshihiro Watanabe, Masayuki Ohtsuka
Source: European Journal of Surgical Oncology (EJSO) - Category: Surgery Source Type: research
Authors: Matti B, Zargar-Shoshtari K Abstract Prostate cancer represents a significant health burden worldwide. The cancer incidence had substantially increased since the introduction of prostate specific antigen (PSA) in cancer screening. This had led to considerable debates among health professionals and epidemiologists, since PSA as a screening tool seemed to be far from perfect. In New Zealand, the controversy was quite prominent in the last three decades, with some advocating the benefits of screening, while others concerned regarding the risk of harms. With the absence of an organised screening programme and ...
Source: New Zealand Medical Journal - Category: General Medicine Tags: N Z Med J Source Type: research
Conclusions: 68Ga-DATA-FAPi-05 is a promising PET tracer in the diagnosis of inconclusive results on 18F-FDG PET/CT. 68Ga-DATA-FAPi-05 is easy to prepare, labelled at room temperatures, which aids kit based preparations. It can be used as an alternative diagnostic option to 18F-FDG PET/CT. It is an ideal theranostic agent for the treatment of various cancers.
Source: Journal of Nuclear Medicine - Category: Nuclear Medicine Authors: Tags: Dosimetry (Poster Session) Source Type: research
Conclusions This review describes how leukocyte-heparanase can be a double-edged sword in tumor progression; it can enhance tumor immune surveillance and tumor cell clearance, but also promote tumor survival and growth. We also discuss the potential of using heparanase in leukocyte therapies against tumors, and the effects of heparanase inhibitors on tumor progression and immunity. We are just beginning to understand the influence of heparanase on a pro/anti-tumor immune response, and there are still many questions to answer. How do the pro/anti-tumorigenic effects of heparanase differ across different cancer types? Does...
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
Conclusions Epidemiological studies have repeatedly helped identify definitive triggers for several diseases. As highlighted in this perspective report, previous studies strongly argue for the interplay between intrinsic factors and putative preventable extrinsic triggers/promoters for CTCL. Given the evidence of geographical regional clustering of CTCL patients, CTCL occurrence in unrelated family members and recent evidence implicating S. aureus in the pathogenesis/progression of CTCL, more research is needed to decipher the precise mechanism by which specific environmental exposures may be driving the pathogenesis of t...
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
The separation of benign from malignant mesothelial proliferations is crucial to patient care, and subtyping of malignant mesotheliomas is important for selection of treatment options and estimating prognosis. These issues can present problems using routine morphology, and a variety of (sometimes controversial) markers have been proposed as aids.
Source: Lung Cancer - Category: Cancer & Oncology Authors: Source Type: research
Stories abound of a “cancer-curing” tea from the forests of Canada. Herbal blends claim to “attack cancer at the DNA level.” For many years, mesothelioma patients have turned to alternative medicines like these as treatment options for the rare asbestos-related cancer. Sometimes these options are a last resort, after traditional treatments fail. They may be used in conjunction with standard treatment (complementary medicine) or on their own as the main approach. But the U.S. Food and Drug Administration (FDA) recently issued warning letters to companies that manufacture or market products claimin...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Tags: Alternative medicine Asparagus Extract BioStar Technology International Budwig Protocol cancer supplements cannabis oil cancer CellAssure Centers for Disease Control and Prevention Chelated Boron Circulatory Detox & Support Syrup compl Source Type: news
More News: Alimta | Alternative and Complementary Therapies | Asbestosis | Babies | Blogging | Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | Complementary Medicine | Education | Environmental Health | HIV AIDS | Hospitals | Immunotherapy | Madagascar Health | Mesothelioma | National Health Service (NHS) | Nurses | Nursing | Schools | Study | Truvada | UK Health